Braskem S.A.
NYSE:BAKChemicals
-$0.40 today
- Market cap
- $343.37M
- Beta
- 0.67
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$11.45
Volume 3.32M
Average 2.97M
BAK Operating Cash Flow
Cash generated by the company's core business operations during the period.
Braskem S.A.NYSE: BAK
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow grows, but more slowly than its trailing trend
Q1 FY2026 operating cash flow of R$4.17B (cash outflow) rose 78.8% year over year, behind the +601.4% change in trailing-twelve-month operating cash flow. Sequentially, it rose 362.6% from the prior quarter.
Context
- Operating cash flow amounted to 5.9% of revenue in FY2025, up 2.7 pp from a year earlier.
- Operating cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +78.8% toward the trailing-twelve-month pace of +601.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
BRL · from the cash flow
- Latest · FY2025
- (4.09B) BRL
- Year-over-year change
- -267.8%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (4.09B) | -267.8% |
| FY2024 | 2024-12-31 | 2.44B | +207.2% |
| FY2023 | 2023-12-31 | (2.27B) | -125.4% |
| FY2022 | 2022-12-31 | 8.95B | -39.5% |
| FY2021 | 2021-12-31 | 14.79B | — |
Operating Cash Flow vs competitors
How BAK compares with its peers on the latest reported figures
- Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +601.4% is the highest of 11, against a peer median of +21.4%.
- Operating cash flow amounts to 9.0% of revenue for BAK, versus a peer median of 18.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$6.04B BRL | +601.4% | — | 9.0% | |
| LTM Mar 2026 | $344.89M USD | -19.1% | -15.4% | 27.9% | |
| LTM Mar 2026 | $170.02M USD | +4.0% | -20.8% | 26.4% | |
| LTM Mar 2026 | $157.87M USD | +23.9% | -2.7% | 6.7% | |
| LTM Mar 2026 | $146.99M USD | +18.9% | -9.1% | 17.9% | |
| LTM Apr 2026 | $119.22M USD | +89.3% | +29.1% | 18.2% | |
| LTM Mar 2026 | $52.37M USD | +210.0% | +134.2% | 194.5% | |
CNLCollective Mining Ltd. | LTM Mar 2026 | $40.86M USD | +70.0% | +36.1% | — |
| LTM Mar 2026 | CA$23.34M CAD | +26.1% | -1.1% | — | |
| LTM Mar 2026 | $20.9M USD | -11.6% | — | 8.9% | |
| LTM Mar 2026 | $16.32M USD | -93.0% | -29.6% | 1.1% | |
| Peer median (excluding BAK) | — | +21.4% | -2.7% | 18.1% | |
Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 13.98B | 47M | (4.58B) | (17.73B) | (9.69B) |
| Depreciation & Amortization | 4.87B | 4.73B | 5.21B | 4.95B | 4.58B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 14.39M | 0 | 10M | 0 | 0 |
| Change in Working Capital | (12.48B) | 3.97B | (3.96B) | 557M | (1.71B) |
| Accounts Receivables | (2.18B) | 4.65B | 72M | 609M | 321.56M |
| Inventory | (7.57B) | 2.14B | 1.81B | (181M) | 2.88B |
| Accounts Payables | 0 | 514M | 0 | 384M | (2.3B) |
| Other Working Capital | (2.73B) | (3.34B) | (5.84B) | (255M) | (2.61B) |
| Other Non-Cash Items | 8.39B | 203M | 1.05B | 14.66B | 2.72B |
| Operating Cash Flow | 14.79B | 8.95B | (2.27B) | 2.44B | (4.09B) |
| Capital Expenditures | (3.42B) | (4.85B) | (4.53B) | (3.76B) | (3.07B) |
| Acquisitions (Net) | 0 | (107M) | (78M) | 203M | 100M |
| Purchases of Investments | 0 | (64.97M) | 0 | 0 | (77.45M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 105.88M |
| Other Investing Activities | 40.65M | 72.97M | 83M | 73M | 0 |
| Investing Cash Flow | (3.38B) | (4.95B) | (4.53B) | (3.49B) | (2.94B) |
| Debt Repayment | (10.97B) | 1.55B | 8.28B | 437M | 3.2B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (5.99B) | (1.35B) | (7M) | (6M) | 0 |
| Other Financing Activities | 0 | 21M | 596M | 38M | (63.8M) |
| Financing Cash Flow | (16.97B) | 225M | 8.87B | 469M | 3.13B |
| Effect of Forex Changes | 377.53M | (444M) | (355M) | 1.38B | 1.1B |
| Net Change in Cash | (5.18B) | 3.79B | 1.72B | 799M | (2.79B) |
| Free Cash Flow | 11.37B | 4.1B | (6.8B) | (1.33B) | (7.16B) |
Braskem S.A.
NYSE:BAK
Intrinsic Alpha fair value
Locked
Current Price
$0.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.